This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sabine Pilari: Innovator in Pharmaceutical Research
Introduction
Sabine Pilari is a notable inventor based in Berlin, Germany. She is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. Despite having no granted patents to her name, her contributions to the field of pharmaceutical research are significant.
Latest Patent Applications
Sabine Pilari has been involved in several innovative patent applications. One of her latest applications is titled "Furoindazole Derivatives as Antagonists or Inhibitors of GPR84." This invention covers furoindazole compounds that are designed to treat or prevent various autoimmune diseases, including multiple sclerosis, psoriasis, and rheumatoid arthritis. The application also addresses inflammatory disorders and metabolic conditions, showcasing her commitment to advancing medical science.
Another application she has worked on is simply titled "Furoindazole Derivatives." Similar to her previous application, it focuses on the development of furoindazole compounds for treating autoimmune diseases and inflammatory disorders. These applications highlight her dedication to finding solutions for complex health issues.
Conclusion
Sabine Pilari is an innovative force in the pharmaceutical industry, contributing to the development of new treatments for autoimmune and inflammatory diseases. Her work at Bayer Aktiengesellschaft reflects her commitment to improving health outcomes through research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile